Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Organic Letters|August 13, 2009
Expeditive syntheses of functionalized pentahelicenes and NC-AFM on Ag(001)Sarah Goretta, Christelle Tasciotti, Simon Mathieu, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2016
Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitorsWendy Lee, James J Crawford, Ignacio Aliagas, et al.Journal of Medicinal Chemistry|February 11, 2017
"Addition" and "Subtraction": Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase InhibitorsXin Chen, John Giraldes, Elizabeth R Sprague, et al.ACS Medicinal Chemistry Letters|June 24, 2015
Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor SeriesJoachim Rudolph, Ignacio Aliagas, James J Crawford, et al.Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinaseSteve Wenglowsky, Li Ren, Jonas Grina, et al.Journal of Medicinal Chemistry|June 2, 2015
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J Crawford, Wendy Lee, Ignacio Aliagas, et al.Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.Journal of Medicinal Chemistry|September 7, 2022
Paradoxical Increase of Permeability and Lipophilicity with the Increasing Topological Polar Surface Area within a Series of PRMT5 InhibitorsUpendra Argikar, Markus Blatter, Dallas Bednarczyk, et al.Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.Journal of Medicinal Chemistry|October 12, 2011
Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoformTimothy P Heffron, Binqing Wei, Alan Olivero, et al.Pageof 6